As obesity prevalence increases worldwide, healthcare professionals are often faced with challenging cases associated with massive obesity. A 33-year-old woman (weight 342 kg, body mass index = 100 kg/m²) presented with respiratory failure, limb edema and ascites. Abdominal CT scan became feasible after initial weight loss and showed a large pelvic mass in contact with the left ovary. The surgical removal performed despite a high-risk profile led to the diagnosis of a giant mucinous borderline tumor whose growth was due to delayed care and responsible for multiple severe complications: sepsis, anemia, esophagitis, constipation, anorexia due to mechanical compression, undernutrition, sarcopenia and lower limb edema contributing to a severe disability. After 7 months under specialized care, her weight decreased to 180 kg, complications were treated and disability improved. This case, showing that, despite barriers, a multidisciplinary approach makes quality of care possible even in massively obese patients, is an educational example to reduce stigma.
A 33-year-old woman with extreme obesity (weight 342 kg, body mass index = 100 kg/m²) was admitted to the emergency department with respiratory failure, limb edema and ascites. Her weight had increased over the last months with worsening of her general health status. As her corpulence limited physical examination and excluded standard imaging investigations, she was empirically treated with anticoagulants and antibiotics for a possible pulmonary embolism and pneumonia. She also received a loop diuretic and continuous positive airway pressure was initiated. After initial improvement of her respiratory status, she was transferred to a post-acute rehabilitation department. Ascites remained unchanged despite draining and diuretic treatment. After 5 months under medical supervision and following a controlled diet, she had lost a large amount of weight (−92 kg) but remained disabled, bedridden and needed assistance from 6 professionals for routine hygienic care.
She was referred to our obesity clinic for specialized nutritional care and etiological investigation of ascites. Ascites aspiration revealed a liquid exudate without bacterial pathogens. There was no evidence for hepatitis, cardiac or renal failure. Abdominal and pelvic intra-vaginal ultrasound performed at the patient's bed did not show any effusion in the Douglas pouch or behind the liver. However, we observed a very large abdominal mass of a multicystic nature. Because of technical difficulties, the ultrasonographer could not exclude or confirm an ovarianrelated disease. Although she had experienced substantial weight loss, the patient's body shape still prevented performing standard imaging, such as computed tomography (CT) or magnetic resonance imaging (MRI). A duodenal echo-endoscopy and a proctoscopy were performed and did not show any finding in favor of a gastrointestinal or pancreatic tumor. There were no sign of peritoneal carcinosis either. The marker CA 19-9 was increased (800 U/ml, N < 60) and CA125 was normal. Therefore, an ovarian tumor was the most probable diagnosis. Reviewing the case with the gynecological surgeon led to a decision to operate despite obvious surgical difficulties and a high-risk profile for anesthesia and surgical-related complications in this patient with extreme obesity.
Owing to further patient weight loss, a CT scan became feasible before surgery. It confirmed the presence of a large pelvic cystic mass measuring 40 × 24 × 40 cm, in contact with the left ovary (Fig. 1) . The liver appeared normal. No peritoneal carcinosis was observed. Surgical removal of this mass was performed by laparotomy during a 6 h surgical procedure. Seventeen liters of gelatinous liquid were removed from the mass, which originated from the left ovary. The excised mass weighed 3 kg. Pathological examination concluded the mass was a mucinous borderline tumor without invasive implants. Borderline ovarian tumors (BOTs) account for 10-15% of epithelial tumors. Mucinous BOTs are the second most common tumor type (after serous) and account for 35 to 45% of BOTs. These tumors are usually large, unilateral, composed of multiple cystic spaces with variable diameter [1] . BOTs occur in women around the age of 40 years. The prognostic factors include characteristics of the tumor (stage, peritoneal implants), type of surgery, preoperative CA125, bilateral forms and age, but not obesity.
The major growth in size of that tumor was due, at least in part, to delayed care in an extreme form of obesity and was responsible for multiple severe complications. First, it was probably infected after multiple drains of ascites, and responsible for three episodes of meti-S Staphylococcus aureus sepsis. Second, the patient had several digestive symptoms likely due to mechanical compression from the tumor, which included esophagal reflux with erosive esophagitis, severe constipation with several sub-occlusive episodes and anorexia. These symptoms led to undernutrition with global edemas which required enteral nutrition over the course of a few months. The patient also exhibited severe anemia requiring several blood transfusions. Third, pelvic compression led to aggravation of lower limb venous insufficiency and lymphedema. This state of extreme obesity, associated with undernutrition and sarcopenia, was responsible for disability despite the young age of the patient.
After 7 months of hospitalization under specialized care, albuminemia was normalized and the patient's weight was 180 kg. She could sit alone and required only 2 people helping her with the toilet.
This case illustrates how extreme obesity may mask other comorbidities and highlights some of the difficulties encountered in assessment and management of severely obese patients. First, obese patients are vulnerable to multiple forms of weight bias and stigmatization, and this applies particularly to healthcare settings [2] . Due to past negative experiences with health professionals, these patients may avoid or postpone medical care and present with more advanced and thus more difficult to treat conditions. They can also withdraw from full participation in proposed treatments with reduced adherence to treatment and counseling. In this context, even benign diseases can lead to severe complications and injuries. Second, corpulence exhibited during severe obesity poses a tremendous challenge to clinical diagnosis and treatment such as drug titration especially for anticoagulants and antibiotics but also for transportation and explorations including imaging [3] . As such, conventional MRI and CT scan devices are limited by the gantry size and the table weight limits.
Given increasing obesity rates worldwide [4] , especially increasing rates of massively obese cases, and in order for these patients to receive adequate care in an equitable fashion [5] , the healthcare delivery systems need to adapt and training/education in obesity management need to be developed for healthcare professionals. Adequate transportation and equipment, management and treatment need to be adapted to provide necessary resources at all levels of care to patients with morbid obesity.
